Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors.

MLA

Bai, Bing, et al. “Peptidomimetic Nitrile Warheads as SARS-CoV-2 3CL Protease Inhibitors.” RSC Medicinal Chemistry, vol. 12, no. 10, Aug. 2021, pp. 1722–30. EBSCOhost, https://doi.org/10.1039/d1md00247c.

APA

Bai, B., Arutyunova, E., Khan, M. B., Lu, J., Joyce, M. A., Saffran, H. A., Shields, J. A., Kandadai, A. S., Belovodskiy, A., Hena, M., Vuong, W., Lamer, T., Young, H. S., Vederas, J. C., Tyrrell, D. L., Lemieux, M. J., & Nieman, J. A. (2021). Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors. RSC Medicinal Chemistry, 12(10), 1722–1730. https://doi.org/10.1039/d1md00247c

Chicago

Bai, Bing, Elena Arutyunova, Muhammad Bashir Khan, Jimmy Lu, Michael A Joyce, Holly A Saffran, Justin A Shields, et al. 2021. “Peptidomimetic Nitrile Warheads as SARS-CoV-2 3CL Protease Inhibitors.” RSC Medicinal Chemistry 12 (10): 1722–30. doi:10.1039/d1md00247c.